NasdaqGS - Delayed Quote USD
MacroGenics, Inc. (MGNX)
At close: October 31 at 4:00 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
26.7
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| SNPHF Santen Pharmaceutical Co., Ltd. | 27 | 3 | 16 | 9 |
| NUVL Nuvalent, Inc. | 27 | -- | -- | -- |
| MGNX MacroGenics, Inc. | 27 | -- | -- | -- |
| AUPH Aurinia Pharmaceuticals Inc | 27 | -- | -- | -- |
| KMDA Kamada Ltd. | 27 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
MGNX
Category Average
N/A None Controversy Level
None 4 Severe
-- MGNX
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
MRSN Mersana Therapeutics, Inc.
1.8100
-3.21%
CTMX CytomX Therapeutics, Inc.
0.9957
+0.37%
KPTI Karyopharm Therapeutics Inc.
0.9898
+17.81%
ALXO ALX Oncology Holdings Inc.
1.4300
+3.62%
VINC Vincerx Pharma, Inc.
0.3490
-0.29%
FGEN FibroGen, Inc.
0.3014
-5.16%
ALLO Allogene Therapeutics, Inc.
2.5550
-3.22%
ANAB AnaptysBio, Inc.
21.63
-2.48%
LYEL Lyell Immunopharma, Inc.
0.9603
+11.88%
ZNTL Zentalis Pharmaceuticals, Inc.
2.7300
+1.11%